ALV:XETRAllianz SE Analysis
Data as of 2026-06-22 - not real-time
$118.24
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Autoliv (ALV) is trading at $118.24, which sits below its 20‑day (126.1) and 50‑day (120.2) simple moving averages, indicating short‑term pressure, while still above the identified support at $116.15. The 14‑day RSI of 42 suggests the stock is not yet oversold, and a bearish MACD histogram (-1.61) reinforces a cautious near‑term outlook. Nevertheless, the broader trend is flagged as bullish, and volume is increasing, providing some upside momentum toward the $132.17 resistance level. Valuation metrics appear modest, with a trailing P/E of 12.7 and forward P/E of 9.9, positioning the stock near the lower end of the industry range. The dividend yield of 2.93% and a payout ratio of 35% are comfortably supported by free cash flow of $430 m and a solid ROE of 28%. However, the DCF‑derived fair value of $75.6 is well below the current price, implying that the market is pricing in significant growth expectations. Analyst consensus (17 analysts) is a “Buy” with a median target of $134, implying roughly 12% upside from today’s level.
Risk factors include a beta above 1.1 and 30‑day volatility of 34%, which point to higher price swings, while the auto‑parts sector’s cyclical nature adds medium sector risk. The company’s debt‑to‑equity of 85% raises moderate balance‑sheet concerns, but strong operating cash flow and a diversified geographic footprint mitigate regulatory and currency exposures. Given the mix of solid fundamentals, attractive dividend, and upside potential, the stock is viewed as fairly valued with a blended growth‑value profile. In the short run, a hold stance is prudent, while medium‑ to long‑term horizons merit a buy recommendation.
Risk factors include a beta above 1.1 and 30‑day volatility of 34%, which point to higher price swings, while the auto‑parts sector’s cyclical nature adds medium sector risk. The company’s debt‑to‑equity of 85% raises moderate balance‑sheet concerns, but strong operating cash flow and a diversified geographic footprint mitigate regulatory and currency exposures. Given the mix of solid fundamentals, attractive dividend, and upside potential, the stock is viewed as fairly valued with a blended growth‑value profile. In the short run, a hold stance is prudent, while medium‑ to long‑term horizons merit a buy recommendation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price below short‑term moving averages
- bearish MACD histogram
- proximity to support level
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- analyst buy consensus and target price
- strong dividend yield and payout ratio
- solid ROE and cash flow generation
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- global diversification across automotive markets
- stable demand for safety‑regulation solutions
- sustainable dividend and high ROE
Key Metrics & Analysis
Financial Health
Revenue Growth6.80%
Profit Margin6.45%
P/E Ratio12.7
ROE28.37%
ROA8.38%
Debt/Equity85.17
P/B Ratio3.4
Op. Cash Flow$1.0B
Free Cash Flow$430.4M
Technical Analysis
TrendBullish
RSI41.9
Support$116.15
Resistance$132.17
MA 20$126.10
MA 50$120.20
MA 200$119.46
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46
Valuation
Fair Value$75.62
Target Price$132.88
Upside/Downside12.38%
GradeFair
TypeBlend
Dividend Yield2.93%
Risk Assessment
Beta1.19
Volatility34.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.